Samsung Biologics to Produce mRNA Vaccine Ingredients in Songdo Facility
After scoring the vaccine deal with Moderna, Samsung Biologics said it will add an mRNA vaccine drug substance (DS) production line to the facility in Songdo, which is expected to …
Read More